Tech Company Financing Transactions
Thar Pharmaceuticals Funding Round
Private investors participated in a $115 thousand funding round for Thar Pharmaceuticals. This venture round was announced by the company on 9/2/2014.
Transaction Overview
Company Name
Announced On
9/2/2014
Transaction Type
Debt
Amount
$115,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
150 Gamma Dr.
Pittsburgh, PA 15238
USA
Pittsburgh, PA 15238
USA
Phone
Website
Email Address
Overview
Thar Pharmaceuticals is focused on the identification and development of new forms of widely prescribed drugs that solve clinical opportunities such as improved bioavailability, efficacy, absorption, safety or toxicity. It is estimated that the clinical performance of seventy percent of currently marketed drugs can be improved.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Lalit Chordia
Chief Executive Officer
Raymond Houck
Chief Medical Officer
Ira Kalfus
VP - Regulatory Affairs
Jason Bablak
Browse more venture capital transactions:
Prev: 9/2/2014: Neurovance venture capital transaction
Next: 9/2/2014: Clearside Biomedical venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs